Literature DB >> 15711409

From 'points' to 'profiles' in intracavitary brachytherapy of cervical cancer.

Niloy Ranjan Datta1.   

Abstract

PURPOSE OF REVIEW: This article reviews some recent developments that have occurred with the widespread use of imaging modalities during intracavitary brachytherapy in cervical cancer. RECENT
FINDINGS: The practice of dose prescription with intracavitary brachytherapy continues to be largely based on the traditional hypothetical point - point A. Recent studies have indicated that significant uncertainties could result with such point dose prescriptions. Gradually a shift is perceived towards the incorporation of target and normal structure outlines for dose prescription and treatment planning during intracavitary brachytherapy.
SUMMARY: Dose prescriptions during brachytherapy could be framed with certainty if various imaging modalities are integrated during the intracavitary procedure. With the availability of computerized tomography/magnetic resonance imaging-compatible applicators, dose prescriptions and distributions could be based on either anatomical images of the diseased and normal organs obtained from computerized tomography or magnetic resonance imaging studies or on anatometabolic images after co-registration of the anatomical and functional images obtained from computerized tomography/magnetic resonance imaging and positron emission tomography. A shift from traditional two-dimensional 'points' to three-dimensional 'profiles' for targets and normal tissue doses could be expected in the near future with the use of image-guided intracavitary brachytherapy in cervical cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15711409     DOI: 10.1097/00001703-200502000-00007

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  3 in total

Review 1.  Brachytherapy in cancer cervix: Time to move ahead from point A?

Authors:  Anurita Srivastava; Niloy Ranjan Datta
Journal:  World J Clin Oncol       Date:  2014-10-10

2.  Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.

Authors:  Anis Bandyopadhyay; Arnab Kumar Ghosh; Bappaditya Chhatui; Dhiman Das
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

3.  Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer.

Authors:  Goran Marosevic; Dzenita Ljuca; Hasan Osmic; Semir Fazlic; Oliver Arsovski; Dusan Mileusnic
Journal:  Radiol Oncol       Date:  2014-04-25       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.